Description

Compounded liquid oral GLP-1 is an alternative to injectable GLP-1 medications, offering a convenient, once-daily oral option. It belongs to a class of medications called GLP-1 receptor agonists, which help manage blood sugar levels and appetite. This formulation may support both weight loss and improved blood sugar control, especially when used alongside a healthy diet and regular exercise.

By activating GLP-1 receptors in the body, this medication mimics the natural hormone GLP-1 and produces several key effects:

• Delays stomach emptying, helping you stay fuller for longer
• Stimulates insulin production when blood glucose is elevated
• Reduces glucagon secretion, helping to prevent blood sugar spikes
• Supports appetite control, potentially leading to lower caloric intake

Liquid compounded GLP-1is taken orally and can offer similar metabolic benefits to injectable versions, while simplifying the administration process.

Important Notice:

• This compounded medication is not approved by the FDA. The FDA does not review compounded products for safety, effectiveness, or quality standards.
• Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. ReMDi Health  is not affiliated with Novo Nordisk in any way.